Trial intelligence / Profile preview

Single-dose modafinil or fluoxetine to enhance motor learning

NL-OMON42762Recruiting

Sponsor
Erasmus MC
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Trial of modafinil and fluoxetine (2 arms), sponsored by Erasmus MC. Primary endpoints: Motor learning capacity in random saccade adaptation task, Motor learning capacity in random smooth pursuit adaptation task and 1 more. Started Feb 2016; status: recruiting.

02

Drugs

modafinilfluoxetine

Beyond the preview

Go deeper on NL-OMON42762.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42762.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call